Skip to content
Screener

Eton Pharmaceuticals, Inc. ETON Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

HRO
HarrowHROW
$7.39M+9,139,678,516%
XER
Xeris Biopharma Holdings, Inc.XERS
$21.77M-2.8%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
14.3%+1.7pp
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$785K-39.8%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
4.9%0.0pp
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$17.08M+176%

Other financials

Income statement

See full
Revenue$24.3M+40.4%
Gross profit$14.7M+49.4%
Operating income$2.4M+614%
Net income$1.6M+199%
EPS (diluted)$0.05+183%

Balance sheet

See full
Cash & equivalents$19.7M+12.9%
Total debt$31.3M+3.7%
Total equity$30.6M+25.2%
Total assets$97.7M+16.3%

Cash flow

See full
Operating cash flow$7.4M+254%
CapEx$75.0K
Free cash flow$7.3M+251%

Valuation

See full
Market cap$1.2B+162%
Enterprise value$1.21B+161%
P/S13.8×+5.9×

Profitability

See full
Gross margin54.8%-3.7pp
Operating margin-15.1%
Net margin-9.5%-2.7pp
FCF margin17.1%

Returns & leverage

See full
Return on equity-34.2%+0.9pp
Debt / equity-0.2×
Current ratio1.2×-0.8×

Where this comes from

Reported directly by Eton Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 4:17 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001437749-26-017064
Line itemMarch 31, 2026December 31, 2025
Total current assets53,24560,581
Property and equipment, net372326
Intangible assets, net43,73830,878
Operating lease right-of-use assets, net301310
Other long-term assets, net5419
Total assets$97,710$92,114
Liabilities and stockholders’ equity
Current liabilities:

Document

FAQ

What is Eton Pharmaceuticals, Inc.'s operating lease ROU assets?
Eton Pharmaceuticals, Inc. (ETON) reported operating lease ROU assets of $301K in Q1 2026.
How has Eton Pharmaceuticals, Inc.'s operating lease ROU assets changed year-over-year?
Eton Pharmaceuticals, Inc.'s operating lease ROU assets increased by 90.5% year-over-year, from $158K to $301K.
What is the long-term trend for Eton Pharmaceuticals, Inc.'s operating lease ROU assets?
Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s operating lease ROU assets has grown at a 9.7% compound annual growth rate (CAGR), from $195K to $310K.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Eton Pharmaceuticals, Inc.'s operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude